TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30661948

Group type: EXPERIMENTAL
Intervention: Prostatic artery embolization (PAE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Prostatic artery embolization (PAE) with CGD
Number of subjects: 48
Study: 27990717

Group type: EXPERIMENTAL
Intervention: mirabegron
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study: 25967531

Group type: EXPERIMENTAL
Intervention: Modular orthosis
Number of subjects: 47

Group type: COMPARATOR
Intervention: Invariable orthosis
Number of subjects: 47
Study: 23842003

Group type: EXPERIMENTAL
Intervention: Hib vaccination via vastus lateralis muscle (2 or 3 times at monthly intervals)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Hib vaccination via vastus lateralis muscle (3 times for 2-5 mo group, 2 times for 6-12 mo group)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Hib vaccination via vastus lateralis muscle
Number of subjects: 320

Group type: COMPARATOR
Intervention: Hib vaccination via deltoid muscle
Number of subjects: 320
Study: 22216717

Group type: EXPERIMENTAL
Intervention: Carprofen 2 mg/kg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Carprofen 5 mg/kg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Carprofen 10 mg/kg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Carprofen (all doses combined)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 52
Study: 18640631

Group type: EXPERIMENTAL
Intervention: Wrapped warm footbath (WW Footbath)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 13
Study: 16289322

Group type: EXPERIMENTAL
Intervention: Down's syndrome (DS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mental retardation (MR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 0
Study: 14560413

Group type: EXPERIMENTAL
Intervention: Marathon polyethylene liners (cross-linked with 5.0 Mrad of gamma irradiation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cross-linked polyethylene
Number of subjects: 0
Study: 14674205

Group type: EXPERIMENTAL
Intervention: Endurance training programme for four months
Number of subjects: 77
Study: 8985763

Group type: EXPERIMENTAL
Intervention: Mupirocin nasal ointment
Number of subjects: 1796

Group type: COMPARATOR
Intervention: Concurrent control (unintentionally not treated)
Number of subjects: 1796
Study: 1451552

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPLX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nefloxacin (NFLX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enoxacin (ENX)
Number of subjects: 10
Study: 3965692

Group type: EXPERIMENTAL
Intervention: Marihuana cigarette (1.83% delta 9‐tetrahydrocannabinol)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo cigarette
Number of subjects: 16
Study: 31066486

Group type: EXPERIMENTAL
Intervention: sulfur‐sodium sulfacetamide combination
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 10% crotamiton
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 5% permethrin
Number of subjects: 72
Study: 29024454

Group type: EXPERIMENTAL
Intervention: Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard RA education (comparison group)
Number of subjects: 238
Study: 27114420

Group type: EXPERIMENTAL
Intervention: Laparoscopic fundoplication
Number of subjects: 87
Study: 25042302

Group type: EXPERIMENTAL
Intervention: Massage therapy plus topical analgesic
Number of subjects: 20

Group type: COMPARATOR
Intervention: Massage therapy
Number of subjects: 20
Study: 22313547

Group type: EXPERIMENTAL
Intervention: High-dose venlafaxine xr (up to 300 mg/day) with problem solving therapy for depression and pain (PST-DP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose venlafaxine xr (up to 300 mg/day) and continued supportive management (SM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open treatment with venlafaxine xr 150 mg/day and supportive management (SM)
Number of subjects: 0
Study: 20049491

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBT) 300 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ropinirole (ROP) 0.5 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17329045

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 107

Group type: COMPARATOR
Intervention: LNG-IUS
Number of subjects: 107
Study: 16293863

Group type: EXPERIMENTAL
Intervention: Epirubicin plus paclitaxel (EP) - epirubicin 75 mg/m2 and paclitaxel 200 mg/m2
Number of subjects: 705

Group type: COMPARATOR
Intervention: Epirubicin plus cyclophosphamide (EC) - epirubicin 75 mg/m2 and cyclophosphamide 600 mg/m2
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Epirubicin plus paclitaxel (EP)
Number of subjects: 705

Group type: COMPARATOR
Intervention: Epirubicin plus cyclophosphamide (EC)
Number of subjects: 705
Study: 11955904

Group type: EXPERIMENTAL
Intervention: Peribulbar anesthesia
Number of subjects: 78

Group type: COMPARATOR
Intervention: Topical anesthesia combined with intracameral lidocaine 1%
Number of subjects: 78
Study: 8602382

Group type: COMPARATOR
Intervention: Ranitidine 300 mg at bedtime
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g 4 times/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at bedtime plus sucralfate 1 g 4 times/day
Number of subjects: 20
Study: 2655671

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride (Narcan)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Naltrexone hydrochloride (Trexan)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 871282

Group type: EXPERIMENTAL
Intervention: Improperly fitted mask (Group I and II)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Properly fitted mask (Group III)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: USAF aviator MBU‐5/P mask and A‐14 regulator
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Arterial blood gas measurements
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preliminary data from tissue oxygen measurements
Number of subjects: 17
Study: 31786154

Group type: EXPERIMENTAL
Intervention: Upadacitinib 7.5 mg
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 30946378

Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study: 28266301

Group type: EXPERIMENTAL
Intervention: Written invitation to undergo testing of the stool for blood with an accompanying test
Number of subjects: 35384

Group type: COMPARATOR
Intervention: Written invitation to undergo testing of the stool for blood without an accompanying test
Number of subjects: 35384

Group type: EXPERIMENTAL
Intervention: Written invitation to undergo colonoscopic screening
Number of subjects: 35384
Study: 25757725

Group type: EXPERIMENTAL
Intervention: Modified hatha yoga training (HYG: n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group with no yoga training (CG: n = 9)
Number of subjects: 18
Study: 23619372

Group type: EXPERIMENTAL
Intervention: Transfused symptomatic infants (Hct<0.30, n=32)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non transfused asymptomatic controls (Hct >0.30, n=9)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non transfused asymptomatic controls (Hct <0.30, n=7)
Number of subjects: 48
Study: 21330161

Group type: EXPERIMENTAL
Intervention: Bone condensing technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard drilling technique
Number of subjects: 48
Study: 19454518

Group type: EXPERIMENTAL
Intervention: Puragen
Number of subjects: 68

Group type: COMPARATOR
Intervention: Captique
Number of subjects: 68
Study: 16696806

Group type: EXPERIMENTAL
Intervention: 300 mL white wine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 500 mL beer
Number of subjects: 25

Group type: COMPARATOR
Intervention: tap water (control)
Number of subjects: 25
Study: 15155043

Group type: EXPERIMENTAL
Intervention: Project ALERT intervention (11 lessons in Grade 7 and 3 lessons in Grade 8)
Number of subjects: 4276

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4276
Study: 11052433

Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg administered 2 minutes before releasing the aortic cross-clamp)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline (5 mL administered to control group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline (5 mL)
Number of subjects: 34
Study: 9120797

Group type: EXPERIMENTAL
Intervention: Physical training (bicycle ergometer, 80% AT, 10 min, 2 times a day for 2 weeks from the 15th day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional rehabilitation (non-training group)
Number of subjects: 20
Study: 7801557

Group type: EXPERIMENTAL
Intervention: Differential x-ray diagnosis of respiratory distress syndrome
Number of subjects: 93
Study: 3680471

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Seven-point Likert scale
Number of subjects: 28
Study: 30360984

Group type: EXPERIMENTAL
Intervention: HMB-FA 3 × 1 g/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 16
Study: 30251638

Group type: EXPERIMENTAL
Intervention: Hydrocolloid nasal barrier dressing during CPAP
Number of subjects: 108

Group type: COMPARATOR
Intervention: No barrier dressing during CPAP
Number of subjects: 108
Study: 27223128

Group type: EXPERIMENTAL
Intervention: Systemic azithromycin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral hygiene instructions, subgingival scaling and root planing
Number of subjects: 24
Study: 24502959

Group type: EXPERIMENTAL
Intervention: PKEP
Number of subjects: 160
Study: 22075372

Group type: EXPERIMENTAL
Intervention: Manual acupuncture on ST‐36 and ST‐39
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Electroacupuncture on ST‐36 and ST‐39
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Electroacupuncture on nonacupoints
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study: 21064034

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2a and ribavirin therapy
Number of subjects: 1778
Study: 17582563

Group type: EXPERIMENTAL
Intervention: CVD 908
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CVD 908-htrA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CVD 909
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ty21a (Vivotif)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vi polysaccharide vaccine (Typhim Vi)
Number of subjects: 0
Study: 16128675

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 12399074

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (folic acid 0.4 mg, pyridoxine 120 mg, riboflavin 75 mg per day for 30 days)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 33
Study: 10454691

Group type: EXPERIMENTAL
Intervention: Nimodipine (60 mg taken orally every 4 hours)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Magnesium sulfate (6 g bolus and 2 g/hr intravenous infusion)
Number of subjects: 21
Study: 8521886

Group type: EXPERIMENTAL
Intervention: Firm stents (polyurethane)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Soft stents (Sof‐Flex)
Number of subjects: 155
Study: 2699823

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg buspirone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 606778

Group type: EXPERIMENTAL
Intervention: Split-virus or whole-virus preparations of killed, monovalent influenza A/New Jersey/76 virus vaccine
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Booster dose of split-virus or whole-virus preparations of killed, monovalent influenza A/New Jersey/76 virus vaccine
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 31826815

Group type: EXPERIMENTAL
Intervention: Laparoscopic fundoplication (LF)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Open fundoplication (OF)
Number of subjects: 55
Study: 30822531

Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Passive Scattering Proton Therapy (PSPT)
Number of subjects: 178
Study: 28065872

Group type: EXPERIMENTAL
Intervention: Posterior cervical transfacet fusion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mechanical cervical tractions
Number of subjects: 80
Study: 25596476

Group type: EXPERIMENTAL
Intervention: Maintenance tocolysis with nifedipine (exact dosage and duration not specified)
Number of subjects: 0
Study: 23663341

Group type: EXPERIMENTAL
Intervention: Combined treatment of remifemin (one tablet twice daily) and paroxetine (20 mg once daily) for 2 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paroxetine (20 mg once daily) for 2 months
Number of subjects: 120
Study: 21865351

Group type: COMPARATOR
Intervention: Placebo during fasting
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Metreleptin during fasting
Number of subjects: 7

Group type: COMPARATOR
Intervention: Baseline/isocaloric diet
Number of subjects: 7
Study: 18949459

Group type: EXPERIMENTAL
Intervention: Ketamine (n = 19; mean ketamine blood plasma = 175.29 ng/mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (n = 11)
Number of subjects: 30
Study: 17109338

Group type: EXPERIMENTAL
Intervention: ALVAC vCP1452
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: IL-2 plus vaccine
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 14742176

Group type: EXPERIMENTAL
Intervention: Episodic retrieval under dual-task conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semantic retrieval under dual-task conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cued recall (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition (Experiment 2)
Number of subjects: 0
Study: 11688615

Group type: EXPERIMENTAL
Intervention: Printed information recommending folate intake to decrease the risk of NTDs disseminated in 1997
Number of subjects: 1196
Study: 9778002

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.4 ng/ml (group LS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.8 ng/ml (group MS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sufentanil 1.2 ng/ml (group HS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl 5 ng/ml (group LF)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 ng/ml (group MF)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl 15 ng/ml (group HF)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sufentanil concentrations > or = 1.25 +/- 0.21 ng/ml
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Fentanyl concentrations > or = 13.3 +/- 2.2 ng/ml
Number of subjects: 66

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 66

Group type: COMPARATOR
Intervention: Hemodynamics
Number of subjects: 66
Study: 7869005

Group type: EXPERIMENTAL
Intervention: Intermittent catheterization
Number of subjects: 98

Group type: COMPARATOR
Intervention: Indwelling catheterization
Number of subjects: 98
Study: 3280855

Group type: EXPERIMENTAL
Intervention: Calcium citrate
Number of subjects: 81

Group type: COMPARATOR
Intervention: Aluminum-containing compounds
Number of subjects: 81
Study: 29474190

Group type: EXPERIMENTAL
Intervention: Magnetization of ferrogels and magnetorheological elastomers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic moduli with increasing magnetization
Number of subjects: 0
Study: 27797282

Group type: EXPERIMENTAL
Intervention: STEP technique
Number of subjects: 155

Group type: COMPARATOR
Intervention: Standard needle injection
Number of subjects: 155
Study: 26267861

Group type: EXPERIMENTAL
Intervention: Anodal stimulation (1 mA) over the left dorsolateral prefrontal cortex
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 24183743

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia
Number of subjects: 61

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 61
Study: 21936930

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (LiCO3) plus riluzole
Number of subjects: 220

Group type: COMPARATOR
Intervention: Riluzole alone
Number of subjects: 220
Study: 17995967

Group type: EXPERIMENTAL
Intervention: LED system (120 mW cm(‐2); 40 J cm(‐2), LEDA, WaveLight AG, Erlangen, Germany)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Incoherent lamp (160 mW cm(‐2); 100 J cm(‐2), PDT 1200L, Waldmann Medizintechnik, Villingen‐Schwenningen, Germany)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: LED system
Number of subjects: 17

Group type: COMPARATOR
Intervention: Incoherent lamp
Number of subjects: 17
Study: 16644612

Group type: EXPERIMENTAL
Intervention: Molsidomine once-daily 16 mg (M16)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Molsidomine twice-daily 8 mg (M8)
Number of subjects: 666
Study: 14574035

Group type: EXPERIMENTAL
Intervention: Verapamil (calcium channel blocker)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irbesartan (angiotensin receptor blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rate control strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rhythm control strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anticoagulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trandolapril after myocardial infarction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiologic pacing
Number of subjects: 0
Study: 11080465

Group type: EXPERIMENTAL
Intervention: Caseload midwifery care
Number of subjects: 1505

Group type: COMPARATOR
Intervention: Traditional 'shared care'
Number of subjects: 1505
Study: 8840920

Group type: EXPERIMENTAL
Intervention: Palatable foods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unpalatable foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary restraint (measured by the Three Factor Eating Questionnaire)
Number of subjects: 0
Study: 1497127

Group type: EXPERIMENTAL
Intervention: Flumazenil (Fl) with Fentanyl (Fe)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (Pl) with Fentanyl (Fe)
Number of subjects: 15
Study: 6653134

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Atenolol (100 mg)
Number of subjects: 33
Study: 31718254

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30 mg/day
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 50 mg/day
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 70 mg/day
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30, 50, or 70 mg/day
Number of subjects: 76
Study: 31366435

Group type: COMPARATOR
Intervention: Written vaccination appeal sent by physicians to patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Written vaccination appeal sent to nephrologists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Written vaccination appeal sent by health-insurance fund to patients
Number of subjects: 0
Study: 29130647

Group type: EXPERIMENTAL
Intervention: Transcorneal electrical stimulation (TES)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham control (inactive laser acupuncture)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All interventions (TES, electro-acupuncture, sham control)
Number of subjects: 21
Study: 26794472

Group type: EXPERIMENTAL
Intervention: Narrow-spectrum antibiotics
Number of subjects: 769
Study: 24855214

Group type: EXPERIMENTAL
Intervention: 3D echocardiography (3DE) LV volumes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2D echocardiography (2DE) LV volumes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3D RF ≥40%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3D RF ≤30%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3D RF between 30 and 40%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3D RF
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MR grading by two cardiologists
Number of subjects: 60
Study: 22708519

Group type: EXPERIMENTAL
Intervention: Structural Ecosystems Therapy (SET)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Psycho-educational health group (HG)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Family drug abstinence
Number of subjects: 126
Study: 20179658

Group type: EXPERIMENTAL
Intervention: Albuterol HFA 180 microg
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Albuterol HFA 360 microg
Number of subjects: 87
Study: 17343553

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Stimulants
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Stimulant to Atomoxetine switch
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 16266860

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (sIMV)
Number of subjects: 40
Study: 17008634

Group type: EXPERIMENTAL
Intervention: Baseline SBP <140 mm Hg
Number of subjects: 7697

Group type: EXPERIMENTAL
Intervention: At least 3 consecutive measurements of SBP <120 mm Hg
Number of subjects: 7697
Study: 12580231

Group type: EXPERIMENTAL
Intervention: Automated noninvasive blood pressure (ANIBP) measurements in the arm
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Automated noninvasive blood pressure (ANIBP) measurements in the calf
Number of subjects: 73

Group type: COMPARATOR
Intervention: Comparison of ANIBP measurements between arm and calf
Number of subjects: 73
Study: 8646094

Group type: EXPERIMENTAL
Intervention: High dose bupivacaine
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Low dose bupivacaine with opioid
Number of subjects: 599

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 599

Group type: COMPARATOR
Intervention: No epidural analgesia
Number of subjects: 599